Hydreight Technologies Appoints Dr. Roebuck As a Director of the Company
Hydreight Technologies (OTCQB: HYDTF) has appointed Dr. Jeremy Roebuck as a director of the company, effective May 5, 2025. Dr. Roebuck, who has served on Hydreight's Board of Advisors since December 12, 2022, fills the vacancy created by the resignation of Alexandros Tzilios. Hydreight is a North American integrated mobile clinical network of nurses, doctors, and pharmacy distribution.
Dr. Roebuck expressed enthusiasm about joining the board at a crucial growth phase, highlighting the company's focus on delivering healthcare through a compliant, tech-enabled platform. He aims to contribute to scaling the platform and expanding Hydreight's presence across North America.
Hydreight Technologies (OTCQB: HYDTF) ha nominato Dr. Jeremy Roebuck come nuovo membro del consiglio di amministrazione, con decorrenza dal 5 maggio 2025. Il Dr. Roebuck, che faceva parte del Consiglio di Consulenti di Hydreight dal 12 dicembre 2022, subentra alla posizione lasciata vacante dalla dimissione di Alexandros Tzilios. Hydreight è una rete clinica mobile integrata nordamericana composta da infermieri, medici e distribuzione farmaceutica.
Il Dr. Roebuck ha espresso entusiasmo per l'ingresso nel consiglio in una fase cruciale di crescita, sottolineando l’attenzione dell’azienda nel fornire assistenza sanitaria tramite una piattaforma tecnologica conforme alle normative. Il suo obiettivo è contribuire all’espansione della piattaforma e all’ampliamento della presenza di Hydreight in tutta l’America del Nord.
Hydreight Technologies (OTCQB: HYDTF) ha nombrado a Dr. Jeremy Roebuck como director de la empresa, con efecto a partir del 5 de mayo de 2025. El Dr. Roebuck, quien ha formado parte del Consejo Asesor de Hydreight desde el 12 de diciembre de 2022, ocupa la vacante dejada por la renuncia de Alexandros Tzilios. Hydreight es una red clínica móvil integrada en Norteamérica, compuesta por enfermeros, médicos y distribución farmacéutica.
El Dr. Roebuck manifestó su entusiasmo por unirse a la junta en una etapa crucial de crecimiento, destacando el enfoque de la compañía en ofrecer atención médica a través de una plataforma tecnológica y conforme a las normativas. Su objetivo es contribuir a escalar la plataforma y ampliar la presencia de Hydreight en toda Norteamérica.
Hydreight Technologies (OTCQB: HYDTF)는 Jeremy Roebuck 박사를 2025년 5월 5일부로 이사로 임명했습니다. Roebuck 박사는 2022년 12월 12일부터 Hydreight 자문위원회에서 활동해왔으며, Alexandros Tzilios의 사임으로 생긴 공석을 채우게 됩니다. Hydreight는 간호사, 의사, 약국 유통을 아우르는 북미 통합 모바일 임상 네트워크입니다.
Roebuck 박사는 회사가 중요한 성장 단계에 접어든 시점에 이사회에 합류하게 된 것에 대해 기대감을 표하며, 규정을 준수하는 기술 기반 플랫폼을 통해 의료 서비스를 제공하는 데 중점을 둔 회사의 비전에 공감한다고 밝혔습니다. 그는 플랫폼 확장과 Hydreight의 북미 전역으로의 진출 확대에 기여하고자 합니다.
Hydreight Technologies (OTCQB : HYDTF) a nommé Dr Jeremy Roebuck en tant que directeur de la société, à compter du 5 mai 2025. Le Dr Roebuck, qui siège au conseil consultatif de Hydreight depuis le 12 décembre 2022, remplace Alexandros Tzilios, qui a démissionné. Hydreight est un réseau clinique mobile intégré nord-américain composé d’infirmiers, de médecins et de distribution pharmaceutique.
Le Dr Roebuck a exprimé son enthousiasme à rejoindre le conseil d’administration à une phase cruciale de croissance, soulignant l’accent mis par l’entreprise sur la prestation de soins de santé via une plateforme technologique conforme aux réglementations. Il souhaite contribuer à l’expansion de la plateforme et au renforcement de la présence de Hydreight à travers l’Amérique du Nord.
Hydreight Technologies (OTCQB: HYDTF) hat Dr. Jeremy Roebuck mit Wirkung zum 5. Mai 2025 als Direktor des Unternehmens berufen. Dr. Roebuck, der seit dem 12. Dezember 2022 im Beirat von Hydreight tätig ist, füllt die durch den Rücktritt von Alexandros Tzilios entstandene Vakanz. Hydreight ist ein nordamerikanisches integriertes mobiles klinisches Netzwerk aus Pflegekräften, Ärzten und Apothekenvertrieb.
Dr. Roebuck zeigte sich begeistert, dem Vorstand in einer entscheidenden Wachstumsphase beizutreten, und hob den Fokus des Unternehmens hervor, Gesundheitsversorgung über eine regelkonforme, technikgestützte Plattform anzubieten. Er möchte dazu beitragen, die Plattform zu skalieren und die Präsenz von Hydreight in ganz Nordamerika auszubauen.
- None.
- None.
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) ("Hydreight" or the "Company"), a North American, fully integrated, mobile clinical network of nurses, doctors, and pharmacy distribution, is pleased to announce the appointment of Dr. Jeremy Roebuck as a director of the Company, effective May 5, 2025 to fill the vacancy created by the resignation of Alexandros Tzilios as a director of the Company. The Company thanks Mr. Tzilios for his contribution and wishes him well in his future endeavors. Dr. Roebuck previously served on Hydreight's Board of Advisors since December 12, 2022.
“I’m honored to be joining Hydreight’s Board of Directors at such a pivotal stage in the company’s growth,” said Dr. Jeremy Roebuck. “Hydreight’s vision of delivering high-quality, accessible healthcare through a compliant, tech-enabled platform aligns perfectly with the future of medicine. I’ve been impressed by the team’s execution to date, and I look forward to contributing my experience to help scale the platform, deepen clinical impact, and expand Hydreight’s reach across North America.”
About Dr. Jeremy Roebuck
Dr. Jeremy Roebuck brings over two decades of medical experience to Hydreight's Board. He is a board-certified otolaryngologist specializing in ear, nose, and throat (ENT) disorders, with a subspecialty in neurotology. Dr. Roebuck earned his medical degree from the University of Texas Medical School at Houston, completed his residency in general surgery and otolaryngology, and pursued a fellowship in neurotology at the Minnesota Ear, Head and Neck Clinic in Minneapolis.
Since 2007, Dr. Roebuck has been in private practice at Southeast Texas Ear, Nose & Throat, LLP, where he performed the first cochlear implant and BAHA (bone-anchored hearing aid) surgeries in the Beaumont community. His clinical interests include minimally invasive sinus surgery, balloon sinuplasty, and the treatment of hearing and balance disorders.
In addition to his clinical practice, Dr. Roebuck is the owner and Medical Director of The Med Spa, an innovative facility offering a range of anti-aging, rejuvenation, hydration, and wellness services. These services encompass aesthetic injectables, customized facials, body sculpting, laser therapies, and specialized IV hydration treatments.
Strategic Value to Hydreight
Dr. Roebuck's extensive experience in both clinical practice and medical spa operations positions him as a valuable asset to Hydreight's Board. His dual expertise aligns with Hydreight's mission to bridge the gap between traditional healthcare and accessible, at-home wellness services. Dr. Roebuck's insights into ENT and neurotology is anticipated to inform the expansion of Hydreight's service offerings, while his experience with The Med Spa, in the view of management of Hydreight, will help enhance a practical understanding of integrating medical aesthetics into a mobile platform.
His appointment is expected to enhance Hydreight's strategic initiatives, particularly in expanding its nationwide network of healthcare professionals and diversifying its service portfolio to meet the growing demand for decentralized, patient-centric care.
“We’re incredibly excited to welcome Dr. Jeremy Roebuck to Hydreight’s board of directors,” said Shane Madden, CEO of Hydreight Technologies. “Dr. Roebuck brings a rare combination of clinical expertise and operational experience in both traditional healthcare and medical aesthetics. His insights will be instrumental as we continue expanding our platform’s capabilities across wellness, anti-aging, and direct-to-consumer care. He’s already been an invaluable member of our advisory board, and we’re confident his leadership will help guide Hydreight into its next phase of growth and innovation.”
On behalf of the Board of Directors
Shane Madden
Director and Chief Executive Officer
Hydreight Technologies Inc.
Hydreight Technologies Inc Ranked Number 56 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
Contact
Email: ir@hydreight.com; Telephone: 1 (702) 970-8112
About Hydreight Technologies Inc.
Hydreight Technologies Inc is building one of the largest mobile clinic networks in the United States. Its proprietary, fully integrated platform hosts a network of over 2500 nurses, over 100 doctors and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking, and managing patient data, which enables licensed healthcare professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed healthcare professionals. The Hydreight platform allows healthcare professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network.
About VSDHOne - Direct to Consumer Platform
Developed in partnership with Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FWB: 6F6), Hydreight launched the VSDHOne (Read as VSDH-One) platform. VSDHOne simplifies the entry challenges for companies and medi-spa businesses to enter the online healthcare space compliantly. This platform will help all businesses to launch a direct-to-consumer healthcare brand in a matter of days in all 50 states. Compliant offerings include: GLP-1s (semaglutide, tirzepatide), peptides, personalized healthcare treatments, sermorelin, testosterone replacement therapy (TRT), hair loss, skincare, sexual health and more. Hydreight invested in technology, legal and infrastructure to launch this platform. The VSDHOne platform offers a complete, end-to-end solution for businesses looking to launch direct-to-consumer healthcare brands. From compliance and telemedicine technology to nationwide doctor and pharmacy networks, VSDHOne provides all the tools needed for a seamless entry into the online healthcare space. The platform is designed to significantly reduce the time and costs associated with launching such services, making it possible for businesses to go live in days instead of months.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FAQ
Who is the new director appointed to Hydreight Technologies (HYDTF) board?
Who did Dr. Roebuck replace on Hydreight Technologies' board of directors?
What is Hydreight Technologies' (HYDTF) main business focus?
When did Dr. Roebuck join Hydreight's Board of Advisors before becoming a director?
